Neuromuscular Disorders
Conference Coverage
Dr. Lisa Christopher-Stine: Polymyositis? It’s more likely something else
Thinking polymyositis? Look closely for IMNM, overlap with other rheumatologic conditions, antisynthetase syndrome, inclusion body myositis, and...
Literature Review
Clinical benefits persist 5 years after thymectomy for myasthenia gravis
Patients with generalized nonthymomatous myasthenia gravis who undergo thymectomy may have better long-term clinical outcomes and require less...
From the Journals
Nuedexta mainly prescribed for dementia, Parkinson’s
Only 15.2% of patients had multiple sclerosis or amyotrophic lateral sclerosis, the diagnoses of patients in the studies leading to the approval...
From the Journals
Motor neuron disease spasticity improved with cannabis-based oral spray, antispasticity drugs
Proof-of-concept trial shows encouraging findings that must be confirmed in larger and longer trials.
News from the FDA/CDC
CDC: Acute flaccid myelitis on the decline for 2018
Pattern of reduced cases in November “appears to be repeating.”
FDA/CDC
Firdapse approved: First treatment for rare autoimmune disorder
Amifampridine (Firdapse) has been approved by the FDA for Lambert-Eaton myasthenic syndrome, which affects the nerves’ connection with muscles.
FDA/CDC
CDC: No medical therapy can yet be recommended for acute flaccid myelitis
Updated guidelines find no solid evidence behind any treatment, all which must still be considered anecdotal.
Conference Coverage
Conference News Roundup—American Association of Neuromuscular & Electrodiagnostic Medicine
Conference Coverage
Does Thymectomy Benefit Patients With Anti-MuSK Myasthenia Gravis?
WASHINGTON, DC—Among patients with anti-muscle-specific kinase (MuSK) myasthenia gravis, thymectomy is not associated...
Conference Coverage
Disability in Patients With Stiff Person Syndrome May Progress Faster Than Thought
WASHINGTON, DC—Stiff person syndrome leads to disability if therapy is not initiated early in the disease course,...
Conference Coverage
New Registry Offers Insight Into Opsoclonus-Myoclonus Syndrome
WASHINGTON – Most patients with opsoclonus myoclonus syndrome experience ataxia, among multiple other symptoms.